Haleon Pakistan Limited (HALEON) has reported an exceptional financial performance for the year ended December 31, 2025, showcasing robust growth across key metrics and a significant commitment to shareholder returns. The company's impressive profit surge, coupled with a substantial dividend payout, signals a healthy operational year and a positive outlook for investors.
Financial Performance Highlights
HALEON delivered strong top-line growth, with revenue from contracts with customers increasing by approximately 15.85% to Rs. 43.1 billion in 2025, up from Rs. 37.2 billion in 2024. This revenue expansion translated into even more impressive profitability gains. Gross profit jumped by about 31.47% to Rs. 16.8 billion, significantly improving the gross margin from 34.45% in 2024 to 39.09% in 2025.
Operating profit followed suit, rising by roughly 38.48% to Rs. 10.7 billion, pushing the operating margin from 20.73% to 24.78%. This indicates strong cost management and pricing power. Ultimately, profit after tax soared by approximately 39.19% to Rs. 6.4 billion, compared to Rs. 4.6 billion in the previous year. Consequently, Earnings Per Share (EPS) also saw a healthy increase from Rs. 39.11 to Rs. 54.45.
On the balance sheet, total assets expanded to Rs. 27.2 billion from Rs. 21.8 billion, reflecting growth in the business. Equity also grew substantially to Rs. 14.8 billion from Rs. 12.0 billion. While bank balances decreased from Rs. 6.1 billion in 2024 to Rs. 4.3 billion in 2025, the company strategically increased its investments at amortized cost from Rs. 0.7 billion to Rs. 3.3 billion, indicating active capital deployment. Stock-in-trade also saw a notable increase to Rs. 7.7 billion from Rs. 5.0 billion.
Cash flow from operations remained robust, increasing from Rs. 8.5 billion in 2024 to Rs. 10.4 billion in 2025. However, net cash generated from operating activities saw a decrease to Rs. 5.6 billion from Rs. 6.6 billion, primarily due to a substantial increase in income taxes paid (Rs. 4.6 billion in 2025 vs. Rs. 1.7 billion in 2024).
Key Drivers & Operational Efficiency
Although segment-specific details are not provided in the announcement, the robust revenue growth suggests strong demand for Haleon's consumer healthcare products in the Pakistani market. The significant expansion in both gross and operating margins points towards effective operational efficiencies, a favorable product mix, and potentially successful pricing strategies that have allowed the company to absorb cost pressures and significantly improve profitability.
Management Actions & Shareholder Returns
A key highlight for investors is the generous dividend payout. The Board has recommended a final cash dividend of Rs. 15.00 per share (150%). This is in addition to the interim cash dividends of Rs. 10.00 per share paid in Q2-2025 and Rs. 5.00 per share paid in Q3-2025, bringing the total cash dividend for 2025 to an impressive Rs. 30.00 per share. This demonstrates management's confidence in the company's financial health and its unwavering commitment to returning value to shareholders.
The company also continued its investment in property, plant, and equipment, with payments for acquisitions totaling Rs. 2.0 billion, indicating ongoing capital expenditure to support growth or maintain assets. The notable increase in investment at amortized cost also signals prudent cash management and deployment into income-generating assets, optimizing the company's financial structure.
Investor Takeaway
Haleon Pakistan's 2025 results paint a very positive picture for investors. The company has demonstrated strong financial discipline, translating top-line growth into impressive bottom-line expansion and significant shareholder returns through consistent dividends. The substantial increase in EPS and the attractive total dividend payout make HALEON a compelling stock for income-focused investors and those seeking growth in the resilient consumer healthcare sector.
Investors should continue to monitor the company's ability to sustain its margin improvements and revenue growth momentum in the coming quarters. The strategic deployment of cash into investments rather than just bank balances is a positive sign of active capital management. The upcoming 11th Annual General Meeting on April 28, 2026, will be an opportunity for shareholders to formally approve the recommended dividend and gain further insights into the company's strategic direction.